Literature DB >> 23161749

Haploinsufficiency at the human IFNGR2 locus contributes to mycobacterial disease.

Xiao-Fei Kong1, Guillaume Vogt, Yuval Itan, Anna Macura-Biegun, Anna Szaflarska, Danuta Kowalczyk, Ariane Chapgier, Avinash Abhyankar, Dieter Furthner, Claudia Djambas Khayat, Satoshi Okada, Vanessa L Bryant, Dusan Bogunovic, Alexandra Kreins, Marcela Moncada-Vélez, Mélanie Migaud, Sulaiman Al-Ajaji, Saleh Al-Muhsen, Steven M Holland, Laurent Abel, Capucine Picard, Damien Chaussabel, Jacinta Bustamante, Jean-Laurent Casanova, Stéphanie Boisson-Dupuis.   

Abstract

Mendelian susceptibility to mycobacterial diseases (MSMD) is a rare syndrome, the known genetic etiologies of which impair the production of, or the response to interferon-gamma (IFN-γ). We report here a patient (P1) with MSMD whose cells display mildly impaired responses to IFN-γ, at levels, however, similar to those from MSMD patients with autosomal recessive (AR) partial IFN-γR2 or STAT1 deficiency. Whole-exome sequencing (WES) and Sanger sequencing revealed only one candidate variation for both MSMD-causing and IFN-γ-related genes. P1 carried a heterozygous frame-shift IFNGR2 mutation inherited from her father. We show that the mutant allele is intrinsically loss-of-function and not dominant-negative, suggesting haploinsufficiency at the IFNGR2 locus. We also show that Epstein-Barr virus transformed B lymphocyte cells from 10 heterozygous relatives of patients with AR complete IFN-γR2 deficiency respond poorly to IFN-γ, in some cases as poorly as the cells of P1. Naive CD4(+) T cells and memory IL-4-producing T cells from these individuals also responded poorly to IFN-γ, whereas monocytes and monocyte-derived macrophages (MDMs) did not. This is consistent with the lower levels of expression of IFN-γR2 in lymphoid than in myeloid cells. Overall, MSMD in this patient is probably due to autosomal dominant (AD) IFN-γR2 deficiency, resulting from haploinsufficiency, at least in lymphoid cells. The clinical penetrance of AD IFN-γR2 deficiency is incomplete, possibly due, at least partly, to the variability of cellular responses to IFN-γ in these individuals.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23161749      PMCID: PMC3554203          DOI: 10.1093/hmg/dds484

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  52 in total

1.  Inherited interleukin-12 deficiency: IL12B genotype and clinical phenotype of 13 patients from six kindreds.

Authors:  Capucine Picard; Claire Fieschi; Frédéric Altare; Suliman Al-Jumaah; Sami Al-Hajjar; Jacqueline Feinberg; Stéphanie Dupuis; Claire Soudais; Ibrahim Zaid Al-Mohsen; Emmanuelle Génin; David Lammas; Dinakantha S Kumararatne; Tony Leclerc; Arash Rafii; Husn Frayha; Belinda Murugasu; Lee Bee Wah; Raja Sinniah; Michael Loubser; Emi Okamoto; Abdulaziz Al-Ghonaium; Haysam Tufenkeji; Laurent Abel; Jean-Laurent Casanova
Journal:  Am J Hum Genet       Date:  2001-12-17       Impact factor: 11.025

2.  Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection.

Authors:  E Jouanguy; F Altare; S Lamhamedi; P Revy; J F Emile; M Newport; M Levin; S Blanche; E Seboun; A Fischer; J L Casanova
Journal:  N Engl J Med       Date:  1996-12-26       Impact factor: 91.245

Review 3.  The IFN gamma receptor: a paradigm for cytokine receptor signaling.

Authors:  E A Bach; M Aguet; R D Schreiber
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

Review 4.  Genetic dissection of immunity to mycobacteria: the human model.

Authors:  Jean-Laurent Casanova; Laurent Abel
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

5.  Lack of interferon gamma receptor beta chain and the prevention of interferon gamma signaling in TH1 cells.

Authors:  A Pernis; S Gupta; K J Gollob; E Garfein; R L Coffman; C Schindler; P Rothman
Journal:  Science       Date:  1995-07-14       Impact factor: 47.728

6.  Ligand-induced assembly and activation of the gamma interferon receptor in intact cells.

Authors:  E A Bach; J W Tanner; S Marsters; A Ashkenazi; M Aguet; A S Shaw; R D Schreiber
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

7.  A novel mutation in IFN-gamma receptor 2 with dominant negative activity: biological consequences of homozygous and heterozygous states.

Authors:  Sergio D Rosenzweig; Susan E Dorman; Gulbu Uzel; Stephen Shaw; Amy Scurlock; Margaret R Brown; Rebecca H Buckley; Steven M Holland
Journal:  J Immunol       Date:  2004-09-15       Impact factor: 5.422

8.  Ligand-induced autoregulation of IFN-gamma receptor beta chain expression in T helper cell subsets.

Authors:  E A Bach; S J Szabo; A S Dighe; A Ashkenazi; M Aguet; K M Murphy; R D Schreiber
Journal:  Science       Date:  1995-11-17       Impact factor: 47.728

9.  Interaction between the components of the interferon gamma receptor complex.

Authors:  S V Kotenko; L S Izotova; B P Pollack; T M Mariano; R J Donnelly; G Muthukumaran; J R Cook; G Garotta; O Silvennoinen; J N Ihle
Journal:  J Biol Chem       Date:  1995-09-08       Impact factor: 5.157

10.  Anti-proliferative effect of IFN-gamma in immune regulation. II. IFN-gamma inhibits the proliferation of murine bone marrow cells stimulated with IL-3, IL-4, or granulocyte-macrophage colony-stimulating factor.

Authors:  T F Gajewski; E Goldwasser; F W Fitch
Journal:  J Immunol       Date:  1988-10-15       Impact factor: 5.422

View more
  27 in total

1.  A purely quantitative form of partial recessive IFN-γR2 deficiency caused by mutations of the initiation or second codon.

Authors:  Carmen Oleaga-Quintas; Caroline Deswarte; Marcela Moncada-Vélez; Ayse Metin; Indumathi Krishna Rao; Saliha Kanık-Yüksek; Alejandro Nieto-Patlán; Antoine Guérin; Belgin Gülhan; Savita Murthy; Aslınur Özkaya-Parlakay; Laurent Abel; Rubén Martínez-Barricarte; Rebeca Pérez de Diego; Stéphanie Boisson-Dupuis; Xiao-Fei Kong; Jean-Laurent Casanova; Jacinta Bustamante
Journal:  Hum Mol Genet       Date:  2018-11-15       Impact factor: 6.150

2.  Severe viral respiratory infections in children with IFIH1 loss-of-function mutations.

Authors:  Samira Asgari; Luregn J Schlapbach; Stéphanie Anchisi; Christian Hammer; Istvan Bartha; Thomas Junier; Geneviève Mottet-Osman; Klara M Posfay-Barbe; David Longchamp; Martin Stocker; Samuel Cordey; Laurent Kaiser; Thomas Riedel; Tony Kenna; Deborah Long; Andreas Schibler; Amalio Telenti; Caroline Tapparel; Paul J McLaren; Dominique Garcin; Jacques Fellay
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-17       Impact factor: 11.205

3.  Inherited human IFN-γ deficiency underlies mycobacterial disease.

Authors:  Gaspard Kerner; Jérémie Rosain; Antoine Guérin; Ahmad Al-Khabaz; Carmen Oleaga-Quintas; Franck Rapaport; Michel J Massaad; Jing-Ya Ding; Taushif Khan; Fatima Al Ali; Mahbuba Rahman; Caroline Deswarte; Rubén Martinez-Barricarte; Raif S Geha; Valentine Jeanne-Julien; Diane Garcia; Chih-Yu Chi; Rui Yang; Manon Roynard; Bernhard Fleckenstein; Flore Rozenberg; Stéphanie Boisson-Dupuis; Cheng-Lung Ku; Yoann Seeleuthner; Vivien Béziat; Nico Marr; Laurent Abel; Waleed Al-Herz; Jean-Laurent Casanova; Jacinta Bustamante
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

Review 4.  Mendelian susceptibility to mycobacterial disease: recent discoveries.

Authors:  Jacinta Bustamante
Journal:  Hum Genet       Date:  2020-02-05       Impact factor: 4.132

Review 5.  Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunity.

Authors:  Jacinta Bustamante; Stéphanie Boisson-Dupuis; Laurent Abel; Jean-Laurent Casanova
Journal:  Semin Immunol       Date:  2014-10-26       Impact factor: 11.130

6.  Three Copies of Four Interferon Receptor Genes Underlie a Mild Type I Interferonopathy in Down Syndrome.

Authors:  Xiao-Fei Kong; Lisa Worley; Darawan Rinchai; Vincent Bondet; Puthen Veettil Jithesh; Marie Goulet; Emilie Nonnotte; Anne Sophie Rebillat; Martine Conte; Clotilde Mircher; Nicolas Gürtler; Luyan Liu; Mélanie Migaud; Mohammed Elanbari; Tanwir Habib; Cindy S Ma; Jacinta Bustamante; Laurent Abel; Aimé Ravel; Stanislas Lyonnet; Arnold Munnich; Darragh Duffy; Damien Chaussabel; Jean-Laurent Casanova; Stuart G Tangye; Stéphanie Boisson-Dupuis; Anne Puel
Journal:  J Clin Immunol       Date:  2020-06-22       Impact factor: 8.317

Review 7.  Incomplete penetrance in primary immunodeficiency: a skeleton in the closet.

Authors:  Conor Gruber; Dusan Bogunovic
Journal:  Hum Genet       Date:  2020-02-17       Impact factor: 4.132

8.  Heterozygosity for the Y701C STAT1 mutation in a multiplex kindred with multifocal osteomyelitis.

Authors:  Osamu Hirata; Satoshi Okada; Miyuki Tsumura; Reiko Kagawa; Mizuka Miki; Hiroshi Kawaguchi; Kazuhiro Nakamura; Stéphanie Boisson-Dupuis; Jean-Laurent Casanova; Yoshihiro Takihara; Masao Kobayashi
Journal:  Haematologica       Date:  2013-04-12       Impact factor: 9.941

Review 9.  A genetic perspective on granulomatous diseases with an emphasis on mycobacterial infections.

Authors:  Un-In Wu; Steven M Holland
Journal:  Semin Immunopathol       Date:  2016-01-05       Impact factor: 9.623

Review 10.  IL-12Rβ1 deficiency: mutation update and description of the IL12RB1 variation database.

Authors:  Esther van de Vosse; Margje H Haverkamp; Noe Ramirez-Alejo; Mónica Martinez-Gallo; Lizbeth Blancas-Galicia; Ayşe Metin; Ben Zion Garty; Çağman Sun-Tan; Arnon Broides; Roelof A de Paus; Özlem Keskin; Deniz Çağdaş; Ilhan Tezcan; Encarna Lopez-Ruzafa; Juan I Aróstegui; Jacov Levy; Francisco J Espinosa-Rosales; Özden Sanal; Leopoldo Santos-Argumedo; Jean-Laurent Casanova; Stephanie Boisson-Dupuis; Jaap T van Dissel; Jacinta Bustamante
Journal:  Hum Mutat       Date:  2013-08-08       Impact factor: 4.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.